Sanofi, Exscientia €250M Licensing Deal for Bispecific Drugs Against Metabolic Diseases
Posted on10 May 2017
Comments0
Sanofi and Exscientia signed a potentially €250 million (approximately $273 million) collaboration and license option deal to discover bispecific small-molecule drugs against... Read More